Table 1.

Study data evaluating pregnancy outcomes in women with PSO and PsA (Ben-David et al., 2008, Cohen-Barak et al., 2011, Harder et al., 2014, Lima et al., 2012, Seeger et al., 2007, Yang et al., 2011, Broms et al., 2018)

Statistically significant

Not statistically significant

BMI, body mass index; LBW, low birth weight; LGA, large for gestational age; NR, not reported; PsA, psoriatic arthritis; PSO, psoriasis

^aPrevious abortion was adjusted for maternal age, gestational diabetes mellitus A2, and severe preeclampsia. Cesarean delivery was adjusted for previous cesarean delivery, malpresentation, hypertensive disorders, and labor dystocia.

^bNo adjusting for confounding factors was specified.

^cIncluded 2553 pregnancies; outcomes were adjusted for maternal pre-pregnancy BMI, smoking, weekly alcohol consumption before pregnancy, and maternal age.

^dMultivariate outcomes analysis was adjusted for ethnicity, marital status, education level, depression, hypertension, pregnancies per woman, age, BMI, hospital of delivery, diabetes, assisted reproductive technologies, substance abuse/cigarette smoking, medication use, anemia, and infection.

^eIncluded 197 pregnancies; incidence rate ratios were adjusted for age.

^fOutcomes analysis was adjusted for infant sex and parity, mother’s age, education level, marital status, income, gestational hypertension, diabetes, anemia, and coronary heart disease, as well as the age and education level of the father.

^gMultivariate analyses reported (Model 2) were adjusted for country, maternal age and parity, smoking status, BMI, depression, diabetes and hypertension; separate analyses were performed comparing women with severe and non-severe PSO with women without PSO.

^hModerate preterm birth only (32-36 weeks).